SCHEMBL7644240

SCHEMBL7644240

C=CCNc1ncnc2c1ncn2Cc1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.68
HPGD P15428 3/20 0.67
RAB9A P51151 2/20 0.67
NPC1 O15118 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
PDE4A P27815 1/20 0.59
PDE4B Q07343 1/20 0.59
PDE4C Q08493 1/20 0.59
PDE4D Q08499 1/20 0.59
ADORA2A P29274 4/20 0.56
PI4KA P42356 1/20 0.56
PI4K2B Q8TCG2 1/20 0.56
PI4K2A Q9BTU6 1/20 0.56
PI4KB Q9UBF8 1/20 0.56
HDAC1 Q13547 1/20 0.56
HDAC2 Q92769 1/20 0.56
TMIGD3 P0DMS9 3/20 0.55
ADORA1 P30542 3/20 0.55
ADORA2B P29275 1/20 0.55
KMT2A Q03164 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11459722 0.84 HTT (0.64) HTTHPGDRAB9ANPC1SMN1; SMN2
SCHEMBL17933852 0.84 ADORA2A (0.74) HTTHPGDRAB9ANPC1SMN1; SMN2
SCHEMBL5125772 0.83 HTT (0.73) HTTHPGDRAB9ANPC1SMN1; SMN2
SCHEMBL5122955 0.80 PDE4A (0.85) HTTPDE4APDE4BPDE4CPDE4D
SCHEMBL31088348 0.80 HTT (0.68) HTTHPGDRAB9ANPC1PDE4A
SCHEMBL2049171 0.80 RAB9A (1.00) HTTHPGDRAB9ANPC1SMN1; SMN2
SCHEMBL11463803 0.80 HTT (0.56) HTTHPGDRAB9ANPC1SMN1; SMN2
SCHEMBL1832682 0.77 PDE4A (0.65) HTTHPGDPDE4APDE4BPDE4C
SCHEMBL29133991 0.77 HPGD (0.80) HTTHPGDRAB9ANPC1SMN1; SMN2
SCHEMBL31711721 0.76 HTT (0.75) HTTHPGDRAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-7330770-A None JP disclosed
US-6448261-B1 CORTICOTROPIN RELEASING FACTOR ANTAGONISTS; TREATING ANXIETY, DEPRESSION, AND OTHER PSYCHIATRIC AND NEUROLOGICAL DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-09-10 US disclosed
EP-0901476-A4 ARYLOXY- AND ARYLTHIO-FUSED PYRIDINES AND PYRIMIDINES AND DERIVATIVES DU PONT PHARM CO (US) 2001-08-16 EP disclosed
US-6258809-B1 NERVOUS SYSTEM DISORDERS, ANTIDEPRESSANTS AND PSYCHIATRY DUPONT PHARMACEUTICALS COMPANY 2001-07-10 US disclosed
US-6124300-A Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives DUPONT PHARMACEUTICALS (US) 2000-09-26 US disclosed
US-6107300-A CORTICOTROPIN RELEASING FACTOR ANTAGONIST; PSYCHOLOGICAL DISORDERS DUPONT PHARMACEUTICALS (US) 2000-08-22 US disclosed
EP-0901476-A1 ARYLOXY- AND ARYLTHIO-FUSED PYRIDINES AND PYRIMIDINES AND DERIVATIVES Du Pont Pharmaceuticals Company (US) 1999-03-17 EP disclosed
WO-1997035846-A1 ARYLOXY- AND ARYLTHIO-FUSED PYRIDINES AND PYRIMIDINES AND DERIVATIVES DUPONT PHARMACEUTICALS COMPANY (US) 1997-10-02 WO disclosed
JP-H07330770-A PURINE DERIVATIVE AND TREATING AGENT CONTAINING THE DERIVATIVE AS ACTIVE COMPONENT JAPAN ENERGY CORP 1995-12-19 JP disclosed